Paul Maciocia

11PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPhysiotherapyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 16, 2025
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia.

Nicola Maciocia, Malika Hoekx, Ciaran Acuna

|Dec 23, 2024
CAR T-cell therapies for T-cell malignancies: does cellular immunotherapy represent the best chance of cure?

Nicola Maciocia, Brandon Wade, Paul Maciocia

|Nov 11, 2024
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial.

Kate Cwynarski, Gloria Iacoboni, Eleni Tholouli

|Oct 17, 2024
Single-centre experience of implementing physiotherapist-led prehabilitation for chimeric antigen receptor T cell therapy.

Orla McCourt, Paul Maciocia, Claire Roddie

|Feb 29, 2024
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry.

Pedro Horna, Matthew J Weybright, Mathieu Ferrari

|Feb 21, 2024
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.

Mathieu Ferrari, Matteo Righi, Vania Baldan

Pageof 2

Frequent Collaborators

7 joint publications

Martin Pule

5 joint publications

Mathieu Ferrari

2 joint publications

Giuseppe Gritti

2 joint publications

Amy Burley